News from mimedx, inc

Jul 22, 2014, 16:51 ET

Restrospective Analysis Finds MiMedx EpiFix® As Most Effective In Rapid Resolution Of Diabetic Foot Ulcers When Compared With Two Other Skin Substitutes

 MiMedx Group, Inc. (NASDAQ: MDXG), an integrated developer, processor and marketer of patent protected regenerative biomaterials and...

Jul 15, 2014, 08:42 ET

MiMedx Announces Release Date For 2014 Second Quarter Results

MiMedx Group, Inc. (NASDAQ: MDXG), an integrated developer, processor and marketer of patent protected regenerative biomaterials and bioimplants...

Jul 14, 2014, 10:47 ET

MiMedx Announces Revised Local Coverage Determination From Medicare Contractor That Includes EpiFix®

MiMedx Group, Inc. (NASDAQ: MDXG), an integrated developer, processor and marketer of patent protected regenerative biomaterials and bioimplants...

Jun 19, 2014, 11:15 ET

MiMedx Expects To File Its First Investigational New Drug Application In July

 MiMedx Group, Inc. (NASDAQ: MDXG), an integrated developer, processor and marketer of patent-protected regenerative biomaterials and...

Jun 19, 2014, 10:45 ET

MiMedx Increases Guidance For Second Quarter And Full Year 2014

 MiMedx Group, Inc. (NASDAQ: MDXG), an integrated developer, processor and marketer of patent-protected regenerative biomaterials and...

Jun 04, 2014, 10:02 ET

MiMedx Board Applauds Dismissal Of Lawsuit Against Chairman & CEO

 The Board of Directors of MiMedx Group, Inc. (NASDAQ: MDXG), announced today that the Board applauds the dismissal of the lawsuit brought...

May 27, 2014, 17:15 ET

MiMedx Increases Lower End Of Guidance For Second Quarter And Full Year 2014

 MiMedx Group, Inc.  (NASDAQ: MDXG), an integrated developer, processor and marketer of patent-protected regenerative biomaterials and...

May 23, 2014, 09:02 ET

MiMedx to Present at the Jefferies 2014 Healthcare Conference

 MiMedx (NASDAQ: MDXG), an integrated developer, processor and marketer of patent protected regenerative biomaterials and bioimplants processed...

May 20, 2014, 13:48 ET

MiMedx Declines To Participate In NAD Review Proceeding

MiMedx Group, Inc.  (NASDAQ: MDXG), an integrated developer, processor and marketer of patent protected regenerative biomaterials and...

May 15, 2014, 08:28 ET

MiMedx To Present At The 11th Annual Craig-Hallum Institutional Investor Conference

 MiMedx (NASDAQ: MDXG), an integrated developer, processor and marketer of patent protected regenerative biomaterials and bioimplants...

May 12, 2014, 08:30 ET

MiMedx Announces $10 Million Stock Repurchase Program

 MiMedx Group, Inc. (NASDAQ: MDXG), an integrated developer, manufacturer and marketer of patent-protected regenerative biomaterials and...

May 06, 2014, 16:44 ET

Two New MiMedx Scientific Studies Published In Peer-Reviewed Journals

 MiMedx Group, Inc. (NASDAQ: MDXG), an integrated developer, manufacturer and marketer of patent-protected regenerative biomaterials and...

Apr 29, 2014, 16:41 ET

MiMedx Issued Four New U.S. Patents For Placental Tissue Allografts

 MiMedx Group, Inc. (NASDAQ: MDXG), an integrated developer, manufacturer and marketer of patent-protected regenerative biomaterials and...

Apr 25, 2014, 07:30 ET

MiMedx Announces Record Quarterly Results

 MiMedx Group, Inc.  (NASDAQ: MDXG), an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials...

Apr 23, 2014, 11:12 ET

MiMedx at SAWC Spring 2014: Multiple Studies And Clinical Experience Demonstrate Clinical And Cost Effectiveness Of EpiFix Allograft For Treatment Of Hard-to-Heal Wounds

EpiFix®, dehydrated human amnion/chorion membrane (dHACM) allografts, were shown to be clinically and cost effective in the treatment of...

Apr 22, 2014, 08:30 ET

MiMedx Files Lawsuit Against Liventa, Medline, And Musculoskeletal Transplant Foundation

 MiMedx Group, Inc.  (NASDAQ: MDXG), an integrated developer, manufacturer and marketer of patent-protected regenerative biomaterials and...

Apr 21, 2014, 07:30 ET

MiMedx Sponsors Scott Rigsby, Double-Amputee

 MiMedx Group, Inc.  (NASDAQ: MDXG), an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and...

Apr 07, 2014, 08:30 ET

MiMedx First Quarter Revenue Exceeded Upper End Of Guidance

 MiMedx Group, Inc. (NASDAQ: MDXG), an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials...

Apr 02, 2014, 14:23 ET

MiMedx Group, Inc. Announces Release Date for 2014 First Quarter Results

MiMedx (NASDAQ: MDXG), an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed...

Mar 28, 2014, 14:22 ET

MiMedx to Present at the 13th Annual Needham Healthcare Conference

MiMedx (NASDAQ: MDXG), an integrated developer, manufacturer and marketer of patent  protected  regenerative  biomaterials and...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

ReportBuyer
Research and Markets
Analysts Review